October 4, 2022
Biohaven Launches as a Public Company with $258 Million in Cash, Neuroscience Pipeline
Read More
September 27, 2022
Exicure Cuts All R&D and Two Thirds of Workforce to Stay in Business
Read More
August 30, 2022
Horizon to Expand its Development and Manufacturing Facility in 9Ireland
Read More
August 25, 2022
Aeglea BioTherapeutics Announces Leadership Transition and Corporate Restructuring
Read More
August 17, 2022
Homology Prioritizes Pipeline to Extend Runway, Moves Focus to PKU Gene Editing Trial
Read More
August 11, 2022
ProQR Winds Down Clinical Trials to Focus Exclusively on Axiomer RNA-editing Technology
Read More
July 21, 2022
X4 Cuts Staff, Narrows Focus to Conserve Cash
Read More
July 19, 2022
Invitae to Layoff 1,000 Employees, Names New CEO
Read More
July 13, 2022
Agios Names Brian Goff as CEO
Read More
June 30, 2022
Avadel Cuts Costs to Pursue U.S. Marketing Approval of Narcolepsy Candidate
Read More
June 27, 2022
Alexion Rare Disease to invest $68.9 Million in Manufacturing, R&D in Ireland
Read More
June 21, 2022
Opus Genetics Appoints Yerxa as Permanent CEO
Read More
Load More
X